Search tips
Search criteria 


Logo of toxsciLink to Publisher's site
Toxicol Sci. 2013 January; 131(1): 179–193.
Published online 2012 September 5. doi:  10.1093/toxsci/kfs261
PMCID: PMC3537123

Differential Mouse Pulmonary Dose and Time Course Responses to Titanium Dioxide Nanospheres and Nanobelts


Three anatase titanium dioxide (TiO2) nanoparticles (NPs) were prepared; nanospheres (NSs), short nanobelts (NB1), and long nanobelts (NB2). These NPs were used to investigate the effect of NP shape and length on lung toxicity. Mice were exposed (0–30 µg per mouse) by pharyngeal aspiration and pulmonary toxicity was assessed over a 112-day time course. Whole lung lavage data indicated that NB1- and NB2-exposed mice, but not NS-exposed mice, had significant dose- and time-dependent pulmonary inflammation and damage. Histopathological analyses at 112 days postexposure determined no interstitial fibrosis in any NS-exposed mice, an increased incidence in 30 µg NB1-exposed mice, and significant interstitial fibrosis in 30 µg NB2-exposed mice. At 112 days postexposure, lung burden of NS was decreased by 96.4% and NB2 by 80.5% from initial deposition levels. At 112 days postexposure, enhanced dark field microscopy determined that alveolar macro- phages were the dominant deposition site, but a fraction of NB1 and NB2 was observed in the alveolar interstitial spaces. For the 30 µg exposure groups at 112 days postexposure, confocal micro- scopy and immunofluorescent staining demonstrated that retained NB2 but not NS were present in the interstitium subjacent to the terminal bronchiole near the normal location of the smallest lymphatic capillaries in the lung. These lymphatic capillaries play a critical role in particle clearance, and the accumulation of NB2, but not NS, suggests possible impaired lymphatic clearance by the high aspect ratio particles. In summary, our data indicate that TiO2 NP shape alters pulmonary responses, with severity of responses being ranked as NS < NB1 < NB2.

Key Words: titanium dioxide nanospheres, titanium dioxide nanobelts, pulmonary inflammation, pulmonary fibrosis, pulmonary clearance.

In regards to size, particles ranging from 0.1 to 2.5 µm are considered fine, whereas particles with at least one dimension that is 100nm or less are defined as nanoparticles (NPs) (Wang et al., 2008). Nanomaterials show size-dependent properties that are different from those of bulk materials (Duan et al., 2001; Tan et al., 2003). Examples are titanium dioxide (TiO2) nanomaterials that have been extensively used in various commercial products. TiO2 NPs are used in sunscreen and cosmetics as an ultraviolet absorber that allows an optically transparent film to be applied to human skin (Hayashi and Kobyashi, 1996). TiO2 NPs are also employed as photocatalysts to eliminate pollutants in air, drinking water, and wastewater systems (Tafen et al., 2009; Wu et al., 2010). TiO2 nanospheres (NSs) and nanowires (or nanotubes) are used in dye-sensitized solar cells (DSSCs) (Li et al., 2006; Mor et al., 2006) and biosensors (Yang et al., 2008). Recent studies have revealed that the performance of TiO2 NPs strongly depends on the particle shape. For example, single-crystalline anatase TiO2 nanobelts (NBs) with two dominant surfaces of (101) facets exhibit enhanced photocatalytic activity and higher affinity to oxygen than their NS counterparts with an identical crystal phase and similar specific surface area (Wu et al., 2010). The TiO2 nanowires in the DSSCs have superior performance over their NS counterparts because the nanowire morphology provides direct conduction paths for the electrons from the point of injection to the collection electrode while maintaining high surface area for dye adsorption (Adachi et al., 2004; Baxter and Aydil, 2005). A recent report has further shown TiO2 NBs exhibit better charge transfer performance than NS counterparts (Wang et al., 2010).

Owing to the unique physical and chemical character- istics, engineered nanomaterials may have distinctive biological effects that are different from their bulk counterparts (Holsapple et al., 2005; Nel et al., 2006; Oberdörster et al., 2005). The increasing manufacture and use of nanomaterials has led to concerns regarding both environmental and human exposures to NPs (Colvin, 2003; Dreher, 2004; Maynard and Kuempel, 2005). In order to predict and reduce the risk of potential human health effects associated with manufactured nanomaterials, it is necessary to study their potential toxicological effects. A few epidemiologic studies have been conducted to examine carcinogenicity of fine TiO2 in humans, and concluded that no clear evidence of elevated morbidity or mortality due to lung cancer exists (Boffetta et al., 2001 , 2004; Chen and Fayerweather, 1988; Fryzek et al., 2003; Ramanakumar et al., 2008). However, NIOSH has determined that ultrafine TiO2, which includes nanoscale TiO2, is a potential occupational carcinogen (National Institute for Occupational Safety and Health, 2011).

To date, limited studies have investigated the effect of TiO2 particle shape on toxicity. Primary rat alveolar macrophages (AMs) exposed in vitro to fine-sized particulate and fibrous TiO2 particles reported that the fibrous TiO2 induced a concentration-dependent increase in cytotoxicity but fine-sized spherical TiO2 did not (Watanabe et al., 2002). In another study (Warheit et al., 2006), rats were dosed by intratracheal (IT) instillation with spherical TiO2 NPs, nanosized TiO2 rods, and nanosized TiO2 dots (particle size ~ 10nm). The nanosized TiO2 rods and TiO2 dots produced an acute pulmonary inflammation and cell injury.

In this study, we test the hypothesis that TiO2 NPs with different shape will exhibit different toxicity profiles in vivo. Specifically, we exposed mice to TiO2 NPs with different shapes (NS vs. NB) and NBs with different lengths (short vs. long). Dose and time course responses of pulmonary inflammation and damage were determined in lung lavage, as well as histopathology studies to investigate the development of pulmonary disease.


Synthesis and Characterization of TiO2 NPs

To prepare the NB2 sample, 1.0g of anatase TiO2 powder was added to 75ml of 10M sodium hydroxide aqueous solution. The solution was stirred in ultrasonic bath for 10min, sealed in a 90ml Teflon-lined autoclave, and then heated at 200°C for 24h for hydrothermal treatment. A white fluffy powder was obtained and then washed with 0.1M HCl and deionized water until the pH was less than 7. The white powder sample was heated at 700°C for 30min at a ramp rate of 1°C/min. To obtain NB1, the hydrothermally treated samples were heated at a ramp rate of 10°C/min to break the NBs by thermal gradient–induced stress. For comparison tests, the TiO2 NSs were purchased directly from Alfa Aesar. The nanomaterial samples were observed under a JEOL 7600-F field emission scanning electron microscope (FESEM). The crystal structure of the TiO2 particles was characterized by x-ray diffraction with Cu Kα radiation (XRD, X’Pert Pro PW3040-Pro, Panalytical Inc.).

TiO 2 NP suspension. Suspensions of TiO2 NPs were prepared in dispersion medium (DM; Ca2+- and Mg2+-free PBS, pH 7.4, supplemented with 5.5mM d-glucose, 0.6mg/ml mouse serum albumin, and 0.01mg/ml 1,2-dipalm- itoyl-sn-glycero-3-phosphocholine) as previously described by our laboratory (Porter et al., 2008). Suspensions of NS were sonicated (5W, 15min), whereas NB1 and NB2 were mechanically stirred for 1h.

Measurement of zeta potential of TiO 2 NP. Suspensions of TiO2 NPs (50 µg/ml) were prepared in DM as described above. The zeta potential was measured with a Malvern Zetasizer Nano ZS instrument. For these experiments, the electrophoretic mobility was converted into the zeta potential by means of the Schmolukowski relation.

Animals. Male C57BL/6J mice (6 weeks old) were obtained from Jackson Laboratories (Bar Harbor, ME). Mice were housed one per cage in polycarbonate isolator ventilated cages, which were provided High-Efficiency Particulate Air-filtered air, with fluorescent lighting from 0700h to 1900h. Autoclaved Alpha-Dri virgin cellulose chips and hardwood Beta-chips were used as bedding. Mice were monitored to be free of endogenous viral pathogens, parasites, mycoplasms, Helicobacter, and CAR Bacillus. Mice were maintained on Harlan Teklad Rodent Diet 7913 (Indianapolis, IN), and tap water was provided ad libitum. Animals were allowed to acclimate for at least 5 days before use. All animals used in this study were housed at the NIOSH Animal Quarters (Morgantown, WV), which is an AAALAC-accredited, specific pathogen-free, environmentally controlled facility. All procedures involving animals were approved by the NIOSH Institutional Animal Care and Use Committee.

Pharyngeal aspiration exposure of mice. Suspensions of TiO2 NPs were prepared in DM as described above. Mice were anesthetized with isoflurane (Abbott Laboratories, North Chicago, IL), and, when fully anesthetized, the mouse was positioned with its back against a slant board and suspended by the incisor teeth using a rubber band. The mouth was opened, and the tongue gently pulled aside from the oral cavity. A 50 μl aliquot of sample was pipetted at the base of the tongue, and the tongue was restrained until at least two deep breaths were completed (but for not longer than 15 s). Following release of the tongue, the mouse was gently lifted off the board, placed on its left side, and monitored for recovery from anesthesia. Mice received DM (vehicle control), NS (15 or 30 µg), NB1 (7.5, 15, and 30 µg), or NB2 (1.875, 7.5, 15, and 30 µg).

Whole lung lavage. At 1, 3, 7, 28, and 112 days postexposure, mice were euthanized with an ip injection of sodium pentobarbital (> 100mg/kg body weight) followed by exsanguination. A tracheal cannula was inserted and whole lung lavage (WLL) was performed through the cannula using ice cold Ca2+- and Mg2+-free PBS, pH 7.4, supplemented with 5.5mM d-glucose. The first lavage (0.6ml) was kept separate from the rest of the lavage fluid. Subsequent lavages, each with 1ml of PBS, were performed until a total of 4ml of lavage fluid was collected. WLL cells were isolated by centrifugation (650 × g, 5min, 4°C). An aliquot of the acellular supernatant from the first WLL (WLL fluid) was decanted and transferred to tubes for analysis of lactate dehydrogenase (LDH) and albumin. The acellular supernatants from the remaining lavage samples were decanted and discarded. WLL cells isolated from the first and subsequent lavages for the same mouse were pooled after resuspension in PBS, centrifuged a second time (650 × g, 5min, 4°C), and the supernatant decanted and discarded. The WLL cell pellet was then resuspended in PBS and placed on ice. Total WLL cell counts were obtained using a Coulter Multisizer 3 (Coulter Electronics, Hialeah, FL), and cytospin preparations of the WLL cells were made using a cytocentrifuge (Shandon Elliot Cytocentrifuge, London). The cytospin preparations were stained with modified Wright-Giemsa stain, and cell differentials were determined by light microscopy.

WLL fluid LDH activity and albumin concentration measurements. WLL fluid LDH activities were evaluated as a marker of cytotoxicity. WLL fluid LDH activities were determined by monitoring the LDH-catalyzed oxidation of lactate to pyruvate coupled with the reduction of nicotinamide adenine dinucleotide (NAD) at 340nm using a commercial assay kit (Roche Diagnostics Systems, Montclair, NJ). WLL fluid albumin concentrations were determined as an indicator of the integrity of the blood–pulmonary epithelial cell barrier. WLL fluid albumin was determined colorimetrically at 628nm based on albumin binding to bromcresol green, using a commercial assay kit (Sigma Chemical Company, St Louis, MO). Both the WLL fluid LDH and albumin assays were conducted using a COBAS MIRA Plus (Roche Diagnostic Systems).

Determination of TiO 2 lung burden. Lung samples were placed in sealed vessels for digestion. The following was added to each vessel: 3ml of 70% nitric acid, 1ml of 30% hydrogen peroxide, and 0.1ml of 50% hydrofluoric acid. Either one or two digestion blanks (empty digestion vessels with digestion reagents) were prepared for each digestion set. TiO2 spiked liver tissue controls were run concurrently with the lung samples. All samples and controls were digested using a Milestone Ethos Plus microwave system at 400W power with a temperature set point of 140°C for 10min, followed by a cycle at 600W with a set point of 180°C for 25min. After cooling, the digests were diluted with ultrapure water to ~30g and transferred into precleaned, preweighed polyethylene bottles. The bottles were reweighed to calculate the exact mass of digestate. For DM-exposed mouse lungs, a solution of internal standard Sc (scandium) was then weighed into the digestates. Due to high levels of analyte in the NS and NB2 lung samples, it was necessary to prepare dilutions, which were analyzed in separate analytical runs. The internal standard Sc was also added to the dilutions as a liquid solution. Elemental Ti (47Ti and/or 49Ti) was then quantified using a VG Axiom high-resolution inductively coupled plasma mass spectrometry (ICP-MS) against Ti standards, which also contained the internal standard, from 2 to 100 ppb. The calculation of tissue TiO2 from Ti determinations was done as follows. First, the mass of Ti determined for a sample was divided by the atomic weight of Ti to obtain the number of moles of Ti in that sample. Next, to calculate the mass of TiO2, the number of moles of Ti was multiplied by the molecular weight of TiO2. The basis for the latter calculation is that the number of moles of Ti equals the number of moles of TiO2.

TiO 2 NP visualization in the lung. Sections of the fixed left lung were embedded in paraffin. Sections (5 µm thick) were collected on precleaned slides, deparaffinized, and briefly stained with 1% toluidine blue before being coverslipped. Slides were imaged using a high signal-to-noise, dark field-based illumination on an Olympus BX-41 microscope (CytoViva, Auburn, AL) at ×100 with oil immersion. Verification of the particles imaged as NPs was based on using the CytoViva Hyperspectral imaging system to capture the spectrum (400−1000nm) and matching the spectra of the particle with the spectra from NP-doped standard sections. Images were captured with a Dage MTI digital camera (2048x2048, Dage, Michigan City, IN). Additional images of a calibration slide were taken to ensure accuracy of the magnification.

Histopathology. Mice for histopathology were not lavaged. Mice were euthanized by an overdose of pentobarbital (> 100mg/kg body weight, ip) followed by transection of the abdominal aorta to provide exsanguination. The lungs were rapidly removed and fixed by IT perfusion with 1ml of 10% neutral buffered formalin. Lungs were trimmed the same day, processed overnight in a tissue processor, and embedded in paraffin. The lungs were stained with hematoxylin and eosin for routine morphologic assessment, and with Masson’s trichrome and Sirius Red for evaluating fibrosis.

Demonstration of pulmonary lymphatics by podoplanin and e-cadherin dual-label immunofluorescence. Pulmonary lymphatics were demonstrated using podoplanin and e-cadherin dual-label immunofluorescence as previously described (Porter et al., 2010). In brief, the lymphatics were stained using a hamster anti-podoplanin primary antibody (Novus Biologicals, Littleton, CO) and DyLight conjugated goat anti-hamster secondary antibody (Jackson ImmunoResearch, West Grove, PA). Pulmonary architecture was demonstrated using a mouse anti-e-cadherin primary antibody with an Alexa Fluor 488-labeled donkey anti-mouse secondary antibody (Invitrogen, Carlsbad, CA) secondary antibody. With this technique, lymphatics fluoresce intensely red because of high levels of podoplanin expression (Baluk and McDonald, 2008) without e-cadherin expression, whereas normal pulmonary architecture is demonstrated by e-cadherin staining in epithelium (green), staining of endogenous mouse IgG by the secondary antibody (green), and/or combined e-cadherin and podoplanin staining (orange). This allows both the lymphatics and their location to be demonstrated in tissue sections. Pulmonary lymphatic photomicroscopy was conducted using a Zeiss LSM 510 upright confocal microscope using fluorescence capabilities to demonstrate the lymphatics with superimposed transmitted light to demonstrate NS and NB.

Statistics. Statistical comparisons between doses for each NP at a specific postexposure time were performed separately for each postexposure time using ANOVA with post hoc t-tests for pair-wise comparison of dose groups. Similar analyses were performed to compare postexposure time effect for each NP. Because variance estimates were different across dose groups, the ANOVA models were estimated using an unequal variance model available from SAS PROC MIXED. All statistical tests were two tailed with significance level equal to 0.05.

Because the pathology data consisted of ordinal scores then comparisons between control and TiO2-exposed mice at each time, comparisons across time for each exposure group were accomplished using two separate one-way nonparametric analyses of variance (ANOVAs). Exact tests were used because of the high number of tied values in the data. The nonparametric ANOVA was performed using SAS Proc NPAR1WAY with exact Kruskal-Wallis tests for multigroup comparisons and exact Wilcoxon tests for post hoc pair-wise comparisons. All statistical tests were two tailed and performed at the 0.05 significance level.


Physico-Chemical Properties of TiO2 NPs

SEM images and the corresponding size distributions for NB1 (Fig. 1), NB2 (Fig. 2), and NS (Fig. 3) were determined. Both NB1 and NB2 exhibited NB morphology. A majority of NB1 were 1–5 μm long, with widths between 40–120nm (Fig. 1). Most of the NB2 had lengths from 6–12 μm, and widths between 60–140nm (Fig. 2). The median aspect ratio was around 30 and 80 for NB1 and NB2, respectively. Dry NS had a diameter of 70–190nm (Fig. 3), whereas the hydrodynamic size of NS in DM was determined to be 354.2nm. All three types of TiO2 NPs exhibited the anatase phase as shown in the XRD pattern (Fig. 4). The zeta potentials of the TiO2 NPs in the DM used for the in vivo experiments were −12.4 mV (NS), −12.5 mV (NB1), and −9.35 mV (NB2), respectively.

FIG. 1.
Characterization of NB1 sample. Panel (A) Low magnification SEM image of NB1 sample. Panel (B) High magnification SEM image of NB1 sample. Panel (C) Histogram of lengths of NB1 sample. Panel (D) Histogram of widths of NB1 sample.
FIG. 2.
Characterization of NB2 sample. Panel (A) Low magnification SEM image of NB2 sample. Panel (B) High magnification SEM image of NB2 sample. Panel (C) Histogram of lengths for NB2 sample. Panel (D) Histogram of widths for NB2 sample.
FIG. 3.
Characterization of NS sample. Panel (A) SEM image of NS sample. Panel (B) Size distribution for NS sample.
Fig. 4.
XRD patterns for NS, NB1, and NB2 samples.

WLL Studies

Acute pulmonary inflammation dose responses after exposure to TiO2 NPs were assessed by quantitating WLL polymorphonuclear leukocytes (PMNs) at 1, 3, and 7 days postexposure. Exposure of mice to NS did not cause a significant increase in WLL PMNs versus vehicle control (Fig. 5, panel A). In contrast, mice exposed to NB1 (Fig. 5, panel B) and NB2 (Fig. 5, panel C) both exhibited dose-dependent increases in WLL PMNs versus vehicle-exposed mice. For 30 µg NB1 dose, a nonstatistically significant (p > 0.05) decrease in WLL PMNs was observed at 3 days postexposure in comparison with 1 or 7 days postexposure (Fig. 5, panel B).

FIG. 5.
Acute pulmonary inflammation dose responses after exposure to TiO2 NPs. WLL PMNs were determined at 1, 3, and 7 days postexposure as an indicator of pulmonary inflammation. Panel (A) WLL PMNs determined after exposure to NS. Panel (B) WLL PMNs determined ...

The integrity of the lung blood-gas barrier was assessed by measuring first WLL albumin concentrations. Mice exposed to NS did not have a statistically significant increase in albumin concentrations versus vehicle control (Fig. 6, panel A). NB1-exposed mice had elevated concentrations of albumin in the first WLL fluid at all three postexposure times examined (Fig. 6, panel B). Likewise, mice exposed to NB2 also had elevated concentrations of albumin in the first WLL fluid at all three postexposure times (Fig. 6, panel C).

FIG. 6.
Acute pulmonary first WLL fluid albumin dose responses after exposure to TiO2 NPs. First WLL fluid albumin concentrations were determined at 1, 3, and 7 days postexposure as an indicator of the integrity of the lung blood-gas barrier. Panel (A) First ...

Cytotoxicity in the lung after exposure to TiO2 NPs was assessed from LDH activity in the first WLL after 1, 3, and 7 days postexposure. Mice exposed to NS did not have increased LDH activities versus vehicle control (Fig. 7, panel A). However, mice exposed to 15 and 30 µg NB1 did have significantly increased LDH activities in comparison with DM-exposed controls at 1 and 3 days postexposure, but by 7 days postexposure only the 30 µg NB1-exposed mice were still elevated versus controls (Fig. 7, panel B). Mice exposed to 7.5–30 µg NB2 had significantly higher LDH activities versus DM controls at all three postexposure times (Fig. 7, panel C).

FIG. 7.
Acute pulmonary first WLL fluid LDH dose responses after exposure to TiO2 NPs. First WLL fluid LDH was determined at 1, 3, and 7 days postexposure as an indicator of the cytotoxicity. Panel (A) First WLL fluid LDH activities determined after exposure ...

To determine the time course of pulmonary responses to each nanomaterial, mice were exposed to either DM (vehicle control) or 30 µg of NS, NB1, or NB2 and markers of pulmonary inflammation and damage were assessed from 1–112 days postexposure. In terms of pulmonary inflammation as determined by WLL PMNs, both NB1 and NB2 were significantly higher than DM (vehicle control) and NS at 1, 3, and 7 days postexposure (Fig. 8, panel A). However, by 28 days postexposure, WLL PMNs in all NP-exposed mice were back to control levels. Similarly, first WLL fluid albumin concentrations (Fig. 8, panel B) and first WLL fluid LDH activities (Fig. 8, panel C) for mice exposed to NB1 and NB2 were significantly higher than DM (vehicle control) and NS at 1, 3, and 7 days post- exposure, but at 28 and 112 days postexposure first WLL fluid albumin concentrations and LDH activities for all NP-exposed mice were back to control levels.

FIG. 8.
Time course of pulmonary inflammation and damage after exposure to TiO2 NPs. Panel (A) WLL PMNs were determined as an indicator of pulmonary inflammation. Panel (B) First WLL fluid albumin concentrations were determined as an indicator of the integrity ...

TiO2 Lung Burden and Clearance

Based on the acute time course data, which indicated pulmonary inflammation and damage induced by NS was minimal and damage induced by NB2 was the greatest of the three NPs tested, lung burden and clearance of these two NPs were determined over the 112-day time course (Fig. 9). Initial deposition of NS and NB2 showed similar lung burdens. By 28 days postexposure, lung burden of NS was decreased 69.0% and NB2 by 54.9% from lung burden levels at 1h post- exposure. There was no statistical difference between lung burden of NS and NB2 at 28 days postexposure. By 112 days postexposure, lung burden of NS was decreased 96.4% and NB2 by 80.5% from lung burden levels at 1h postexposure. In contrast to 28 days postexposure, NS lung burden was significantly lower than that for NB2-exposed mice at 112 days postexposure.

FIG. 9.
TiO2 NP lung burden. The lung burdens of TiO2 NS and NB2 were determined from 1h to 112 days postexposure. Values represent means ± SE (n = 5). For a given postexposure time, bars with different letters are significantly different (p < ...

Imaging Studies

As shown in the representative FESEM micrographs (Fig. 10) obtained at 112 days postexposure, large concentrations of NPs were observed in the interior of the AMs for both NB1 and NB2 as well as in the NS-treated lungs.

FIG. 10.
FESEM showing interior view of AMs isolated from mice exposed to DM, NS (30 µg), NB1 (30 µg), or NB2 (30 µg) at 112 days postexposure. Arrows indicate NPs within AMs.

Enhanced dark field microscopy examination of mice exposed to DM, NS (30 µg), NB1 (30 µg), or NB2 (30 µg) at 112 days postexposure showed that AMs were the dominant deposition site for all three types of TiO2 NPs in this study (Fig. 11). NSs outside of AMs were rarely observed as essentially all NSs were cleared by AM. However, fractions of NB1 and NB2 were observed in the alveolar interstitial spaces.

FIG. 11.
Enhanced dark field microscopy examination of mice exposed to DM, NS (30 µg), NB1 (30 µg), or NB2 (30 µg) at 112 days postexposure. NSs and NBs are generally white against the dull colored background of tissue in these images. ...


Histopathology scores for alveolitis, alveolar histiocytosis, phagocytosed NPs, and interstitial fibrosis are presented in Table 1. Phagocytosed TiO2 NPs in AMs were significantly higher for mice exposed to NS (7.5 and 30 µg) and NB1 (30 µg) at both 28 and 112 days postexposure compared with vehicle-exposed controls. There was also a tendency for the NBs to cluster or aggregate within cell cytoplasm of AMs compared with the NSs. The NSs tended to be slightly more dispersed within the cytoplasm of AMs that had phagocytosed the administered material (Supplementary figure 1).

Summary of Histopathological Findings

Histopathological examination of the tracheobronchial lymph nodes also showed phagocytosed NB1 and NB2 at the 30 µg dose more frequently than NS at 28 days postexposure with persistence of phagocytosed NPs at 112 days postexposure. Phagocytosis of NS (30 µg dose) was also more evident in tracheobronchial lymph nodes at 112 days postexposure compared with 28 days postexposure.

Alveolitis had the highest incidence and composite score for the 30 µg NB2-exposed mice at 28 days postexposure compared with other affected groups. At 112 days postexposure, alveolitis was uniformly minimal and fewer of the treated groups had alveolitis.

Interstitial fibrosis was only observed in mice exposed to 30 µg NB1 and NB2 at 28 days postexposure, although neither was significantly higher in comparison with DM-exposed vehicle controls. At 112 days postexposure, interstitial fibrosis persisted at an increased incidence for 30 µg NB1-exposed mice, but was still not significantly increased versus DM-exposed mice. In addition, the 7.5 µg NB1 group had a single incidence of interstitial fibrosis. In contrast, mice exposed to 30 µg NB2 at 112 days postexposure had interstitial fibrosis that was significantly increased versus DM-exposed controls.

A detailed histopathologic evaluation for infiltrates in the interstitium subjacent to the epithelium at the bronchioloalveolar junction in the 30 µg dose at the 112-day-postexposure time point was conducted to evaluate cellular infiltrates corresponding to particle accumulation near bronchiolar lymphatics (see below). Histiocytic inflammation subjacent to the epithelium of the terminal bronchioles was not observed in NS-exposed mice (Fig. 12, panel A) but subtle histiocytic inflammation was observed in three of six mice exposed to NB1 (Fig. 12, panel B) and four of six mice exposed to NB2 (Fig. 12, panel C).

FIG. 12.
Bronchioloalveolar junction at 112 days postexposure to 30 µg TiO2 NPs. Panel (A) Normal bronchioloalveolar junction in a NS-exposed mouse. Panel (B) Rare NB1 (arrows) and small numbers of infiltrating histiocytes (*) in a NB1-exposed mouse. Panel ...

Confocal Dual-Label Immunofluorescence

Confocal dual-label immunofluorescence for e-cadherin and podoplanin in mice at 112 days postexposure to the highest dose revealed important differences between NS and NB in sites of particle accumulation and suggested a role for the peribronchiolar lymphatic capillaries in this altered deposition. In NS-exposed mice, normal lymphatics were demonstrated in perivascular and periobronchiolar locations without evidence of NS accumulation (Fig. 13, panels A and B). In the six NB1-exposed mice, peribronchiolar lymphatics were unusually prominent in two mice (Fig. 13, panel C) and in two other mice NBs could be demonstrated in the perivascular and peribronchiolar interstitium (Fig. 13, panel D), a common site for pulmonary lymphatics. In NB2-exposed mice, NB aggregates at the bronchioloalveolar junction were observed in all six mice (Fig. 13, panel E). Dilated peribroncholar lymphatics were observed in two NB2-exposed mice (Fig. 13, panel E) and NB could be demonstrated within the endothelium of the dilated lymphatics in these mice (Fig. 13, panel F). No changes were observed in the subpleural lymphatics in any exposure group.

FIG. 13.
Podoplanin/e-cadherin dual-label immunofluorescence at 112 days postexposure to 30 µg of a TiO2 NP. Podoplanin (red) is expressed in lymphatic endothelium and alveolar type I cells. E-cadherin (green) is expressed in the intercellular junction ...


The overall hypothesis of this study was that NPs with different shapes will exhibit different pulmonary toxicity profiles in vivo. To test this hypothesis, TiO2 NPs with the same crystalline structure (anatase), but with different shapes, that is, NSs (spherical) and NBs (fiber-like), were prepared. The NBs also had different lengths, with NB1 being shorter than NB2. Thus, in addition to examining the effect of NP shape we also were able to test the effect of NB length on lung toxicity.

Pulmonary inflammation was assessed by quantitating WLL PMNs and histopathologically by assessing alveolitis. Exposure of mice to NS, at lung burdens of 30 µg or less, caused no pulmonary inflammation at any postexposure time as assessed by either endpoint. This finding is similar to previous studies in both mice and rats using various exposure techniques. Mice exposed by whole body inhalation to anatase TiO2 (25nm) reported no pulmonary inflammation (Rossi et al., 2010). In another study, rats that received nanoscale TiO2 dots by IT instillation only had transient pulmonary inflammation and cell injury at 1 day postexposure (Warheit et al., 2006), whereas another rat IT study (Cho et al., 2010) reported no pulmonary inflammation 24h postexposure to TiO2 NSs (30–40nm).

In contrast to NS, mice exposed to NB1 and NB2 had dose-dependent pulmonary inflammation as measured by WLL PMNs, with increases induced by NB1 being less than NB2. For both NB1- and NB2-exposed mice, WLL PMNs returned to vehicle-exposed control levels by 28 days postexposure. Alveolitis tended to be minimal and focal albeit with a greater incidence and distribution in mice exposed to NB2 than NB1 at 30 µg dose level, suggesting not only the length of these NPs but the dosage played a role in the development of pulmonary inflammation, an observation consistent with the WLL PMN data.

To date, limited studies have investigated the effect of TiO2 particle shape on toxicity. Primary rat AMs exposed in vitro to fine-sized particulate and fibrous TiO2 particles reported that the fibrous TiO2 (1–2 μm long) induced a concentration-dependent increase in LDH release, whereas particulate spherical TiO2 (particle size = 1.8 μm) did not (Watanabe et al., 2002). In an in vivo study of TiO2 NPs (Warheit et al., 2006), rats received nanoscale TiO2 rods (particle size, 200 × 35nm) or nanoscale TiO2 dots (particle size ~ 10nm) by IT instillation. The nanoscale TiO2 rods and TiO2 dots only produced transient pulmonary inflammatory and cell injury effects at 24h postexposure. In this study, in contrast to TiO2 NS, mice exposed to NB1 and NB2 had dose-dependent pulmonary inflammation and damage, with increases induced by NB1 being less than NB2. For both NB1- and NB2-exposed mice, pulmonary inflammation and damage returned to vehicle-exposed control levels by 28 days postexposure. Because fiber length is a major determinant of toxicity (Donaldson et al., 2006), and the length of the nanorods studied by Warheit et al. (2006) was very small (200nm) compared with NB1 and NB2 in our study, it is not surprising that NB1 and NB2 induced greater pulmonary inflammation and damage.

Enhanced dark field microscopy determined that AMs were the dominant location for all three types of NPs at 112 days postexposure. In the case of the spherical NPs, NSs outside of AMs were rarely observed as essentially all NSs were cleared by AMs. For NB1- and NB2-exposed mice, a small fraction of the NBs were also observed in the alveolar interstitial spaces. This suggests that AMs were more efficient at phagocytosis and clearance of the NS particles than the NB particles. This hypothesis is supported by histopathological findings that NS- and NB1-exposed mice had higher levels of phagocytosed NPs in relation to NB2-exposed mice, and lung burden data that showed greater clearance of NS than NB2 NPs from the lung at 112 days postexposure.

The lymphatics are a major route for particle clearance from the lung to the lung-associated lymph nodes (Harmsen et al., 1985, 1987; Lauweryns and Baert, 1974; Takahashi and Patrick, 1987). For micron-sized spherical particles, transport in the lymphatics is within phagocytic cells (Harmsen et al., 1985, 1987). Migration of phagocytic cells into the lymphatics is controlled at the level of small lymphatic capillaries, which have no basement membrane and are lined by a loose endothelium that plays a critical role in transmigration of phagocytic cells (Johnson and Jackson, 2008; Pepper and Skobe, 2003). In our study, we were able to use podoplanin staining in conjunction with e-cadherin to visualize the lymphatics of the deep lung (Baluk and McDonald, 2008; Kambouchner and Bernaudin, 2009; Porter et al., 2010). The smallest lymphatic capillaries were seen in the interstitium adjacent to the terminal bronchioles near the bronchioloalveolar junction. We saw an accumulation of NBs, but not NS, in the interstitium of the bronchioloalveolar junction and dilated lymphatics containing intraendothelial NBs were occasionally observed. This suggests that macrophages containing NBs migrated to the site of lymphatic capillaries but lymphatic clearance may have been altered, suggesting the lymphatics as a potential site for the impaired clearance seen in the NB2-exposed mice.

Interestingly, in workers exposed to asbestos, a durable high aspect ratio particle, early changes in the deep lung occur within the wall of the smallest airways of the human lung, the respiratory bronchioles, and the adjacent alveolar ducts (Craighead et al., 1982; Roggli et al., 2010 ; Wright and Churg, 1984), which are also the location of small lymphatic capillaries (Leak, 1980). In addition, the formation of new lymphatics, lymphangiogenesis, is associated with chronic obstructive pulmonary disease and severity of airway obstruction in man (Hardavella et al., 2012). In addition, abnormal lymphangiogenesis extending into the alveolar region of the lung is associated with idiopathic pulmonary fibrosis in man (El-Chemaly et al., 2009). We have previously described dilation of peribronchiolar and subpleural lymphatics in mice aspirating multiwalled carbon nanotubes (MWCNTs) (Porter et al., 2010). Importantly, inflammation can cause lymphangiogenesis (Baluk et al., 2005; El-Chemaly et al., 2008). Therefore, additional studies will be needed to determine whether (1) the increased prominence and dilation of pulmonary lymphatics is a response to inflammation associated with impaired clearance of high aspect ratio particles or (2) the lymphatic changes contribute to the impaired clearance of high aspect ratio particles, such as NB2 and MWCNTs.

Within the AM itself, incorporation of NBs was complete with relatively few NBs found to be protruding outside the cell body, as determined by FESEM. The generally complete incorporation is significantly different from other NPs of similar dimensions. For instance, MWCNTs are frequently observed to partially penetrate AMs as well as other cell membranes such as the alveolar epithelium of the lungs (Porter et al., 2010).

Data obtained in this study suggest that the differential inflammatory responses to the TiO2 NPs in this study are dependent on clearance of the NPs. Assessment of WLL PMNs showed that mice exposed to NS did not cause significant inflammation, but mice exposed to NB1 and NB2 did. By 28 days postexpos- ure, WLL PMNs in all NP-exposed mice were back to control levels. However, alveolitis for the 30 µg NB2-exposed mice at 28 days postexposure remained significantly elevated compared with vehicle-exposed controls. At 112 days postexpos- ure, WLL PMNs for all exposure groups were back to control levels and alveolitis was uniformly minimal and fewer of the treated groups had alveolitis. These observations are consistent with clearance of the NPs from the lung, which showed lung burden of NS decreased by 69.0% at 28 days postexposure and by 96.4% at 112 days postexposure. For NB2, lung burden was decreased by 54.9% at 28 days postexposure, and at 112 day postexposure by 80.5%.

Furthermore, several lines of evidence also suggest that the differential fibrotic responses to the TiO2 NPs in this study are dependent on differential clearance of the NPs, which in turn is related to shape differences. The lung burden of NS was significantly lower than NB2 at 112 days postexposure, indicating that NSs were cleared better from the lung. This is consistent with the observations made using enhanced dark field micro- scopy, which showed that AMs contained NS and NPs were rarely observed outside the AMs, whereas NB2 were observed in both AMs and in the alveolar interstitial spaces. The basis for the difference in clearance of NS and NB2 is likely due to difference in shape, that is, sphere versus fiber-like morphology. The length of the NB2 NPs (6–12 µm) is equal to or greater than diameter of the mouse AM, which has been reported to be 7.23±0.55 µm (Stone et al., 1992). This may have led to some of the NB2 escaping AM-mediated phagocytosis, allowing them to enter the alveolar interstitial spaces, and these NB2 NPs are likely responsible for the decreased lung clearance. Because NB2 exposure, but not NS, significantly increased pulmonary fibrosis at 112 days postexposure, it seems reasonable that it is possible that the fraction of NB2 that escaped AM-mediated phagocytosis and entered the alveolar interstitial space contributes to the development of fibrosis.

A previously published study from our research group compared the in vitro responses of mouse primary AMs with the same three TiO2 NPs examined in this study (Hamilton et al., 2009). One of the major findings of that study was that primary AMs exhibit differential responses to TiO2 NPs based on differences in their shape. In addition, the ranking of these nanomaterials was NS < NB1 < NB2. Thus, the overall conclusion regarding the in vitro toxicity of these TiO2 nanomaterials is entirely consistent with the in vivo study results reported here. In addition, we reported that NB2 activated the NLRP3 inflammasome in vitro, whereas NS and NB1 did not. We are currently investigating if NS and NB2 exhibit a similar differential activation of the NLRP3 inflammasome in vivo. Because inflammasome activation is known to occur in response to other well-known human health hazards, such as silica and asbestos, investigating the possible differential activation of the NLRP3 inflammasome by NS and NB2 may offer additional insights into the mechanisms participating in the development of fibrosis.

In summary, our data indicate that TiO2 NP shape and length affect pulmonary responses. In terms of pulmonary inflammation and damage caused by exposure to the three TiO2 NPs tested in this study, the potency is NS < NB1 < NB2. Of the three TiO2 NPs tested, only the NBs caused development of pulmonary fibrosis, which correlated with the severity of pulmonary inflammation. The archetype paradigm to predict fiber toxicity suggests that fibers that have a diameter < 3 µm, length > 15 µm, and are biopersistant should be considered as potentially pathogenic. Recently it has been determined that these same physiochemical properties may also predict pathogenicity of fiber-like nanomaterials, based on studies that have reported length-dependent toxicity of MWCNTs (Murphy et al., 2011 ; Poland et al., 2008) and nickel nanowires (Poland et al., 2011). Data from this study determined pulmonary toxicity and pathogenesis is related to TiO2 NP shape and length, thus adding to the evidence that the archetype paradigm to predict fiber toxicity also applies to fiber-like nanomaterials.


Supplementary data are available online at


National Science Foundation (CBET-0834233, CBET-1065931); The National Institute of Environmental Health Sciences (1RC2ES018742-01, P20 RR017670 to A.H.). The resource and facilities used at West Virginia University were partially supported by National Science Foundation (EPS 1003907).


  • Adachi M., Murata Y., Takao J., Jiu J., Sakamoto M., Wang F. (2004). Highly efficient dye-sensitized solar cells with a titania thin-film electrode composed of a network structure of single-crystal-like TiO2 nanowires made by the “oriented attachment” mechanism. J. Am. Chem. Soc. 126, 14943–14949. [PubMed]
  • Baluk P., McDonald D. M. (2008). Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann. N. Y. Acad. Sci. 1131, 1–12. [PubMed]
  • Baluk P., Tammela T., Ator E., Lyubynska N., Achen M. G., Hicklin D. J., Jeltsch M., Petrova T. V., Pytowski B., Stacker S. A, et al. (2005). Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115, 247–257. [PMC free article] [PubMed]
  • Baxter J. B., Aydil E. S. (2005). Nanowire-based dye-sensitized solar cells. Appl. Phys. Lett. 86, 053114–0531146.
  • Boffetta P., Gaborieau V., Nadon L., Parent M. F., Weiderpass E., Siemiatycki J. (2001). Exposure to titanium dioxide and risk of lung cancer in a population-based study from Montreal. Scand. J. Work Environ. Health 27, 227–232. [PubMed]
  • Boffetta P., Soutar A., Cherrie J. W., Granath F., Andersen A., Anttila A., Blettner M., Gaborieau V., Klug S. J., Langard S, et al. (2004). Mortality among workers employed in the titanium dioxide production industry in Europe. Cancer Causes Control 15, 697–706. [PubMed]
  • Chen J. L., Fayerweather W. E. (1988). Epidemiologic study of workers exposed to titanium dioxide. J. Occup. Med. 30, 937–942. [PubMed]
  • Cho W. S., Duffin R., Poland C. A., Howie S. E., MacNee W., Bradley M., Megson I. L., Donaldson K. (2010). Metal oxide nanoparticles induce unique inflammatory footprints in the lung: Important implications for nanoparticle testing. Environ. Health Perspect. 118, 1699–1706. [PMC free article] [PubMed]
  • Colvin V. L. (2003). The potential environmental impact of engineered nanomaterials. Nat. Biotechnol. 21, 1166–1170. [PubMed]
  • Craighead J. E., Abraham J. L., Churg A., Green F. H., Kleinerman J., Pratt P. C., Seemayer T. A., Vallyathan V., Weill H. (1982). The pathology of asbestos-associated diseases of the lungs and pleural cavities: Diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch. Pathol. Lab. Med. 106, 544–596. [PubMed]
  • Donaldson K., Aitken R., Tran L., Stone V., Duffin R., Forrest G., Alexander A. (2006). Carbon nanotubes: A review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol. Sci. 92, 5–22. [PubMed]
  • Dreher K. L. (2004). Health and environmental impact of nanotechnology: Toxicological assessment of manufactured nanoparticles. Toxicol. Sci. 77, 3–5. [PubMed]
  • Duan D. M., Wu N. Q., Slaughter W. S., Mao S. X. (2001). Length scale effect on mechanical behavior due to strain gradient plasticity. Mat. Sci. Eng. A 303, 241–249.
  • El-Chemaly S., Levine S. J., Moss J. (2008). Lymphatics in lung disease. Ann. N. Y. Acad. Sci. 1131, 195–202. [PMC free article] [PubMed]
  • El-Chemaly S., Malide D., Zudaire E., Ikeda Y., Weinberg B. A., Pacheco-Rodriguez G., Rosas I. O., Aparicio M., Ren P., MacDonald S. D, et al. (2009). Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proc. Natl Acad. Sci. U.S.A. 106, 3958–3963. [PubMed]
  • Fryzek J. P., Chadda B., Marano D., White K., Schweitzer S., McLaughlin J. K., Blot W. J. (2003). A cohort mortality study among titanium dioxide manufacturing workers in the United States. J. Occup. Environ. Med. 45, 400–409. [PubMed]
  • Hamilton R. F., Wu N., Porter D., Buford M., Wolfarth M., Holian A. (2009). Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part. Fibre Toxicol. 6, 35. [PMC free article] [PubMed]
  • Hardavella G., Tzortzaki E. G., Siozopoulou V., Galanis P., Vlachaki E., Avgousti M., Stefanou D., Siafakas N. M. (2012). Lymphangiogenesis in COPD: Another link in the pathogenesis of the disease. Respir. Med. 106, 687–693. [PubMed]
  • Harmsen A. G., Mason M. J., Muggenburg B. A., Gillett N. A., Jarpe M. A., Bice D. E. (1987). Migration of neutrophils from lung to tracheobronchial lymph node. J. Leukoc. Biol. 41, 95–103. [PubMed]
  • Harmsen A. G., Muggenburg B. A., Snipes M. B., Bice D. E. (1985). The role of macrophages in particle translocation from lungs to lymph nodes. Science 230, 1277–1280. [PubMed]
  • Hayashi H., Kobyashi R. (1996). Daily doses and new technologies about UV protection in patents. Fragrance J. 24, 53–58.
  • Holsapple M. P., Farland W. H., Landry T. D., Monteiro-Riviere N. A., Carter J. M., Walker N. J., Thomas K. V. (2005). Research strategies for safety evaluation of nanomaterials, part II: Toxicological and safety evaluation of nanomaterials, current challenges and data needs. Toxicol. Sci. 88, 12–17. [PubMed]
  • Johnson L. A., Jackson D. G. (2008). Cell traffic and the lymphatic endothelium. Ann. N. Y. Acad. Sci. 1131, 119–133. [PubMed]
  • Kambouchner M., Bernaudin J. F. (2009). Intralobular pulmonary lymphatic distribution in normal human lung using D2-40 antipodoplanin immunostaining. J. Histochem. Cytochem. 57, 643–648. [PubMed]
  • Lauweryns J. M., Baert J. H. (1974). The role of the pulmonary lymphatics in the defenses of the distal lung: Morphological and experimental studies of the transport mechanisms of intratracheally instillated particles. Ann. N. Y. Acad. Sci. 221, 244–275. [PubMed]
  • Leak L. V. (1980). Lymphatic removal of fluids and particles in the mammalian lung. Environ. Health Perspect. 35, 55–75. [PMC free article] [PubMed]
  • Li B., Wang L. D., Kang B. N., Wang P., Qiu Y. (2006). Review of recent progress in solid-state dye-sensitized solar cells. Sol. Energ. Mat. Sol. C 90, 549–573.
  • Maynard A. D., Kuempel E. D. (2005). Airborne nanostructured particles and occupational health. J. Nanopart. Res. 7, 587–614.
  • Mor G. K., Varghese O. K., Paulose M., Shankar K., Grimes C. A. (2006). A review on highly ordered, vertically oriented TiO2 nanotube arrays: Fabrication, material properties, and solar energy applications. Sol. Energ. Mat. Sol. C 90, 2011–2075.
  • Murphy F. A., Poland C. A., Duffin R., Al-Jamal K. T., Ali-Boucetta H., Nunes A., Byrne F., Prina-Mello A., Volkov Y., Li S, et al. (2011). Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am. J. Pathol. 178, 2587–2600. [PubMed]
  • National Institute for Occupational Safety and Health (2011). Current Intelligence Bulletin 63: Occupational Exposure to Titanium Dioxide. Department of Health and Human Services, Cincinnati, OH: pp. 119.
  • Nel A., Xia T., Madler L., Lin N. (2006). Toxic potential of materials at the nanolevel. Science 311, 622–627. [PubMed]
  • Oberdörster G., Oberdörster E., Oberdörster J. (2005). Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113, 823–839. [PMC free article] [PubMed]
  • Pepper M. S., Skobe M. (2003). Lymphatic endothelium: Morphological, molecular and functional properties. J. Cell Biol. 163, 209–213. [PMC free article] [PubMed]
  • Poland C. A., Byrne F., Cho W. S., Prina-Mello A., Murphy F. A., Davies G. L., Coey J. M., Gounko Y., Duffin R., Volkov Y, et al. (2011). Length-dependent pathogenic effects of nickel nanowires in the lungs and the peritoneal cavity. Nanotoxicology. [PubMed]
  • Poland C. A., Duffin R., Kinloch I., Maynard A., Wallace W. A., Seaton A., Stone V., Brown S., Macnee W., Donaldson K. (2008). Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 3, 423–428. [PubMed]
  • Porter D. W., Hubbs A. F., Mercer R. R., Wu N., Wolfarth M. G., Sriram K., Leonard S., Battelli L., Schwegler-Berry D., Friend S, et al. (2010). Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 269, 136–147. [PubMed]
  • Porter D., Sriram K., Wolfarth M., Jefferson A., Schwegler-Berry D., Andrew M., Castranova V. (2008). A biocompatible medium for nanoparticle dispersion. Nanotoxicology 2, 144–154.
  • Ramanakumar A. V., Parent M. E., Latreille B., Siemiatycki J. (2008). Risk of lung cancer following exposure to carbon black, titanium dioxide and talc: Results from two case-control studies in Montreal. Int. J. Cancer 122, 183–189. [PubMed]
  • Roggli V. L., Gibbs A. R., Attanoos R., Churg A., Popper H., Cagle P., Corrin B., Franks T. J., Galateau-Salle F., Galvin J, et al. (2010). Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society. Arch. Pathol. Lab. Med. 134, 462–480. [PubMed]
  • Rossi E. M., Pylkkänen L., Koivisto A. J., Vippola M., Jensen K. A., Miettinen M., Sirola K., Nykasenoja H., Karisola P., Stjernvall T, et al. (2010). Airway exposure to silica-coated TiO2 nanoparticles induces pulmonary neutrophilia in mice. Toxicol. Sci. 113, 422–433. [PubMed]
  • Stone K. C., Mercer R. R., Gehr P., Stockstill B., Crapo J. D. (1992). Allometric relationships of cell numbers and size in the mammalian lung. Am. J. Respir. Cell Mol. Biol. 6, 235–243. [PubMed]
  • Tafen D. N., Wang J., Wu N., Lewis J. P. (2009). Visible light photocatalytic activity in nitrogen-doped TiO(2) nanobelts. Appl. Phys. Lett. 94, 093101-1–093101-3.
  • Takahashi S., Patrick G. (1987). Patterns of lymphatic drainage to individual thoracic and cervical lymph nodes in the rat. Lab. Anim. 21, 31–34. [PubMed]
  • Tan G. L., Hömmerich U., Temple D., Wu N. Q., Zheng J. G., Loutts G. (2003). Synthesis and optical characterization of CdTe nanocrystals prepared by ball milling process. Scripta Materialia 48, 1469–1474.
  • Wang J., Manivannan A., Wu N. (2008). Sol-gel derived La(0.6)Sr(0.4)CoO(3) nanoparticles, nanotubes, nanowires and thin films. Thin Solid Films 517, 582–587.
  • Wang D., Zhao H., Wu N., El Khakani M. A., Ma D. (2010). Tuning the charge-transfer property of PbS-quantum dot/TiO(2)-nanobelt nanohybrids via quantum confinement. J. Phys. Chem. Lett. 1, 1030–1035.
  • Warheit D. B., Webb T. R., Sayes C. M., Colvin V. L., Reed K. L. (2006). Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: Toxicity is not dependent upon particle size and surface area. Toxicol. Sci. 91, 227–236. [PubMed]
  • Watanabe M., Okada M., Kudo Y., Tonori Y., Niitsuya M., Sato T., Aizawa Y., Kotani M. (2002). Differences in the effects of fibrous and particulate titanium dioxide on alveolar macrophages of Fischer 344 rats. J. Toxicol. Environ. Health A 65, 1047–1060. [PubMed]
  • Wright J. L., Churg A. (1984). Morphology of small-airway lesions in patients with asbestos exposure. Hum. Pathol. 15, 68–74. [PubMed]
  • Wu N., Wang J., Tafen D. N., Wang H., Zheng J. G., Lewis J. P., Liu X., Leonard S. S., Manivannan A. (2010). Shape-enhanced photocatalytic activity of single-crystalline anatase TiO(2) (101) nanobelts. J. Am. Chem. Soc. 132, 6679–6685. [PMC free article] [PubMed]
  • Yang M., Wang J., Li H., Zheng J.-G., Wu N. N. (2008). A lactate electrochemical biosensor with a titanate nanotube as direct electron transfer promoter. Nanotechnology 19, 075502. [PubMed]

Articles from Toxicological Sciences are provided here courtesy of Oxford University Press